MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $325,557 | +950.2% | 1,089 | +317.2% | 0.00% | – |
| Q1 2021 | $31,000 | -80.3% | 261 | -80.7% | 0.00% | – |
| Q4 2020 | $157,000 | +220.4% | 1,355 | +233.7% | 0.00% | – |
| Q3 2020 | $49,000 | -53.3% | 406 | -58.5% | 0.00% | – |
| Q2 2020 | $105,000 | +517.6% | 978 | +249.3% | 0.00% | – |
| Q1 2020 | $17,000 | -85.2% | 280 | -77.8% | 0.00% | – |
| Q4 2019 | $115,000 | -68.5% | 1,261 | -70.2% | 0.00% | – |
| Q3 2019 | $365,000 | -85.1% | 4,235 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $2,445,000 | -25.9% | 23,329 | -11.5% | 0.00% | -33.3% |
| Q1 2019 | $3,301,000 | +1526.1% | 26,350 | +1366.3% | 0.00% | – |
| Q4 2018 | $203,000 | -67.3% | 1,797 | -38.0% | 0.00% | – |
| Q3 2018 | $620,000 | -21.9% | 2,898 | +2.0% | 0.00% | -100.0% |
| Q2 2018 | $794,000 | +467.1% | 2,841 | +136.8% | 0.00% | – |
| Q1 2018 | $140,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthCor Management, L.P. | 902,601 | $100,342,000 | 3.87% |
| L1 Capital Pty Ltd | 113,464 | $12,608,000 | 2.35% |
| Avoro Capital Advisors LLC | 1,225,000 | $136,183,000 | 2.34% |
| Tao Capital Management LP | 51,396 | $5,714,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 316,000 | $35,130,000 | 1.20% |
| ACUTA CAPITAL PARTNERS, LLC | 32,500 | $3,613,000 | 0.98% |
| Capital Impact Advisors, LLC | 24,351 | $2,707,000 | 0.66% |
| Baker Brothers Advisors | 1,499,213 | $166,668,000 | 0.63% |
| Rock Springs Capital Management LP | 256,768 | $28,545,000 | 0.60% |
| SHIKIAR ASSET MANAGEMENT INC | 12,000 | $1,334,000 | 0.48% |